Melvin Sharoky M.D., Director at PAR PHARMACEUTICAL COMPANIES, INC. (PRX), bought 20,000 shares at $17.33 ($346K) on 2008-03-05, disclosed to the SEC on 2008-03-07.
Open-market purchase of $346k PRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.16 | 2,000 | $34K | 9.9% |
| 2 | $17.20 | 2,000 | $34K | 9.9% |
| 3 | $17.21 | 2,000 | $34K | 9.9% |
| 4 | $17.25 | 2,000 | $35K | 10.0% |
| 5 | $17.31 | 2,000 | $35K | 10.0% |
| 6 | $17.32 | 2,000 |
| $35K |
| 10.0% |
| 7 | $17.33 | 2,000 | $35K | 10.0% |
| 8 | $17.42 | 4,000 | $70K | 20.1% |
| 9 | $17.45 | 2,000 | $35K | 10.1% |
| Total | $17.31 avg | 20,000 | $346K | 100% |
| Filing → |
| INSM | SELL | 2025-09-15 | $2.9M | — | Filing → |
| INSM | SELL | 2025-08-21 | $1.3M | — | Filing → |
| INSM | SELL | 2025-08-14 | $1.2M | — | Filing → |